Gracell Biotechnologies (GRCL)
NASDAQ:GRCL
US Market
Holding GRCL?
Track your performance easily

Gracell Biotechnologies (GRCL) Stock News & Sentiment

134 Followers
Gracell Biotechnologies Acquisition Completed
Premium
Press Releases
Gracell Biotechnologies Acquisition Completed
9M ago
Gracell Biotechnologies Announces Shareholders’ Approval of Merger Agreement
Premium
Press Releases
Gracell Biotechnologies Announces Shareholders’ Approval of Merger Agreement
9M ago
Gracell Biotechnologies Announces FDA Clearance of IND Application for Phase 1 Clinical Trial of FasTCAR-T GC012F as Early-Line Treatment of Multiple Myeloma
Premium
Press Releases
Gracell Biotechnologies Announces FDA Clearance of IND Application for Phase 1 Clinical Trial of FasTCAR-T GC012F as Early-Line Treatment of Multiple Myeloma
10M ago
M & A News: Bristol-Myers Squibb (NYSE:BMY) to Buy RayzeBio for $4.1B
Premium
Market News
M & A News: Bristol-Myers Squibb (NYSE:BMY) to Buy RayzeBio for $4.1B
11M ago
M & A News: AstraZeneca (NASDAQ:AZN) to Acquire Gracell for $1.2B
Premium
Market News
M & A News: AstraZeneca (NASDAQ:AZN) to Acquire Gracell for $1.2B
11M ago
Gracell Biotechnologies to be acquired by AstraZeneca, furthering cell therapy ambition across oncology and autoimmune diseases
Premium
Press Releases
Gracell Biotechnologies to be acquired by AstraZeneca, furthering cell therapy ambition across oncology and autoimmune diseases
11M ago
Gracell Biotechnologies Announces China NMPA Clearance for IND Application for Phase 1/2 Clinical Trial of FasTCAR-T GC012F for the Treatment of Refractory Systemic Lupus Erythematosus
Premium
Press Releases
Gracell Biotechnologies Announces China NMPA Clearance for IND Application for Phase 1/2 Clinical Trial of FasTCAR-T GC012F for the Treatment of Refractory Systemic Lupus Erythematosus
11M ago
More GRCL News >

News Score - Last 7 Days

Neutral
GRCL
Sector Average
Media Buzz
This Week1 articles
Weekly Average5.75 articles
News Sentiment
This Week100%
Sector Average63%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GRCL’s Media Buzz Sentiment?
1 articles about GRCL were published this week. In an average week, 5.75 articles are published.
    What is GRCL’s weekly average amount of articles?
    In an average week, 5.75 articles about GRCL are published.
      What is GRCL’s News Sentiment?
      100% of articles about GRCL were positive this week, compared to its sector average of 63%.
        Healthcare Stocks that are Trending in the News
        PENPenumbra
        ATNMActinium Pharmaceuticals
        OMIOwens & Minor
        NEONeoGenomics
        EVHEvolent Health
        Showing the stocks with the most bullish news sentiment over the past week
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis